Bura Vinod Kumar, Srivastava Rahul, Chawla Anil Kumar, Njambe Tondo Opute Emmanuel, Khanal Sudhir, Sangal Lucky, Jha Shreya, Bahl Sunil
World Health Organization, Regional Office for South-East Asia, New Delhi, India.
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Indian J Med Res. 2024;160(3&4):267-278. doi: 10.25259/IJMR_1527_2024.
Vaccination is one of the most successful and cost-effective interventions designed by science which has helped in preventing millions of deaths, especially in children. The Expanded Programme on Immunization (EPI) was established by World Health Organization (WHO) in 1974 to develop immunization programmes throughout the world with polio, measles, diphtheria, tetanus, tuberculosis and whooping cough. The WHO South-East Asia Region (SEAR) has a disproportionately high burden of infectious diseases and has greatly benefitted from the EPI as compared to other regions with more than 90 per cent of the population having access to vaccines. The story of vaccines in South-East Asia is a testament to scientific progress, global collaboration, and unwavering commitment to public health. This article aims to discuss the journey of EPI in the WHO SEAR.
疫苗接种是科学设计的最成功且最具成本效益的干预措施之一，它帮助预防了数百万人死亡，尤其是儿童死亡。世界卫生组织（WHO）于1974年设立了扩大免疫规划（EPI），以在全球范围内开展针对脊髓灰质炎、麻疹、白喉、破伤风、结核病和百日咳的免疫规划。世卫组织东南亚区域（SEAR）的传染病负担格外沉重，与其他区域相比，该区域从扩大免疫规划中受益匪浅，超过90%的人口能够接种疫苗。东南亚的疫苗故事证明了科学进步、全球合作以及对公共卫生的坚定承诺。本文旨在探讨扩大免疫规划在WHO东南亚区域的历程。
